BDBM50328439 (1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-1,2,4-triazol-3-ylthio)propyl)-1-(4-(trifluoromethyl)phenyl)bicyclo[3.1.0]hexan-3-amine::(2R,5S)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-1,2,4-triazol-3-ylthio)propyl)-5-(4-(trifluoromethyl)phenyl)bicyclo[3.1.0]hexan-2-amine::CHEMBL1258035

SMILES Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@@]3(CC23)c2ccc(cc2)C(F)(F)F)n1C

InChI Key InChIKey=VTGDLGOSPAKXEA-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50328439   

TargetCytochrome P450 1A2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 251nMAssay Description:Displacement of [3H]-dofetilide from human ERG by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50328439((1S,3R)-N-(3-(4-methyl-5-(4-methyloxazol-5-yl)-4H-...)
Affinity DataIC50: 251nMAssay Description:Displacement of [3H]-dofetilide from human ERG by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2011
Entry Details Article
PubMed